| scholarly article | Q13442814 |
| P2093 | author name string | Gert Klug | |
| Regina Esterhammer | |||
| Bernhard Metzler | |||
| Agnes Mayr | |||
| Johannes Mair | |||
| Hans-Josef Feistritzer | |||
| Sebastian Johannes Reinstadler | |||
| Angelika Hammerer-Lercher | |||
| Katrin Streil | |||
| Kerstin Bader | |||
| Bettina Harrasser | |||
| P2860 | cites work | Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction | Q28278894 |
| Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling | Q33862454 | ||
| Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction | Q33917874 | ||
| C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study | Q34003454 | ||
| Incremental value of copeptin for rapid rule out of acute myocardial infarction | Q34018239 | ||
| Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction | Q35240779 | ||
| The quantification of infarct size | Q35920417 | ||
| Prognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance. | Q36288870 | ||
| Vasopressin antagonism in heart failure | Q36312330 | ||
| Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications | Q37850831 | ||
| Assessing myocardial recovery following ST-segment elevation myocardial infarction: short- and long-term perspectives using cardiovascular magnetic resonance | Q38081156 | ||
| Vasopressin as vasopressor | Q39661134 | ||
| Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study | Q40145488 | ||
| Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors | Q41087614 | ||
| C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction | Q43795750 | ||
| Release kinetics of copeptin in patients undergoing transcoronary ablation of septal hypertrophy. | Q43948807 | ||
| Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge | Q44353713 | ||
| Hemodynamic effects of infused arginine vasopressin in congestive heart failure | Q45174469 | ||
| C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study | Q46061278 | ||
| Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin | Q46790418 | ||
| Possible vascular role of increased plasma arginine vasopressin in congestive heart failure | Q46830711 | ||
| Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance | Q47202825 | ||
| Cardiac troponin T and creatine kinase predict mid-term infarct size and left ventricular function after acute myocardial infarction: a cardiac MR study. | Q47383987 | ||
| Predictive value of NT-pro BNP after acute myocardial infarction: relation with acute and chronic infarct size and myocardial function | Q47587026 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 1525-1529 | |
| P577 | publication date | 2013-05-22 | |
| P1433 | published in | Heart | Q856338 |
| P1476 | title | Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction | |
| P478 | volume | 99 |
| Q22252541 | A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction |
| Q89462488 | Aortic Stiffness and Infarct Healing in Survivors of Acute ST-Segment-Elevation Myocardial Infarction |
| Q92353919 | Association of Serum Copeptin Levels with Patency of Infarct-Related Arteries in Patients with ST-Segment Elevation Myocardial Infarction |
| Q35556679 | Biomarkers of hemodynamic stress and aortic stiffness after STEMI: a cross-sectional analysis. |
| Q51593784 | Cardiac index after acute ST-segment elevation myocardial infarction measured with phase-contrast cardiac magnetic resonance imaging. |
| Q39293604 | Combined biomarker testing for the prediction of left ventricular remodelling in ST-elevation myocardial infarction |
| Q35001626 | Comparison of an oscillometric method with cardiac magnetic resonance for the analysis of aortic pulse wave velocity |
| Q35556651 | Copeptin testing in acute myocardial infarction: ready for routine use? |
| Q57101391 | Diagnostic accuracy of adding copeptin to cardiac troponin for non-ST-elevation myocardial infarction: A systematic review and meta-analysis |
| Q35809242 | Fetuin-A is related to infarct size, left ventricular function and remodelling after acute STEMI. |
| Q48727533 | N-terminal pro-B-type natriuretic peptide is associated with aortic stiffness in patients presenting with acute myocardial infarction |
| Q38841682 | Novel biomarkers predicting cardiac function after acute myocardial infarction |
| Q41520470 | Predictive value of plasma copeptin level for the risk and mortality of heart failure: a meta-analysis |
| Q40459010 | Prognostic significance of transaminases after acute ST-elevation myocardial infarction: insights from a cardiac magnetic resonance study. |
| Q36942164 | Prognostic value of left ventricular global function index in patients after ST-segment elevation myocardial infarction. |
| Q51627539 | Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction. |
| Q30442265 | Relation of plasma adiponectin levels and aortic stiffness after acute ST-segment elevation myocardial infarction |
| Q41632039 | Revisiting myocardial necrosis biomarkers: assessment of the effect of conditioning therapies on infarct size by kinetic modelling |
| Q47969196 | The positive predictive value of ct-proAVP (copeptin) in patients with STEMI. |
| Q38253152 | The prognostic value of copeptin in patients with acute chest pain |
Search more.